Mednet Logo

What patient factors most strongly influence your decision to start biologic agents in mild cognitive impairment?

Specifically, what guidelines do you use to help determine this (if any)?
1 Answer
Mednet Member
Mednet Member
Neurology · Mount Sinai Medical Center
Answered on

1.Absence of need for anticoagulants ( this is exclusionary)

2. Absence of APOE e4 homozygosity (although we do treat e4 homozygotes, but with much greater precautionary measures - especially the dosing protocol)

3. High functional ability, and adherence to healthy lifestyle measures (exercise, die...

Join for free or sign in to see the full answer